Albany Molecular Research Inc. (AMRI) has entered a collaboration with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharma and biopharma clients.   For a period of three years, AMRI gains access to NYCNMR’s nanoscale therapeutic and formulation services, and NYCNMR’s customers will have access to AMRI’s drug discovery services, which includes assay method development, high-throughput screening, high-content screen...